GOLDMAN SACHS GROUP INC - ATHIRA PHARMA INC ownership

ATHIRA PHARMA INC's ticker is ATHA and the CUSIP is 04746L104. A total of 72 filers reported holding ATHIRA PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ATHIRA PHARMA INC
ValueSharesWeighting
Q2 2023$51,377
-84.1%
17,416
-86.6%
0.00%
Q1 2023$323,973
-39.9%
129,589
-23.8%
0.00%
Q4 2022$538,912
+13.7%
170,004
+6.5%
0.00%
Q3 2022$474,000
-77.7%
159,700
-77.1%
0.00%
Q2 2022$2,127,000
+96.2%
697,203
+767.8%
0.00%
Q1 2022$1,084,000
-15.6%
80,341
-18.6%
0.00%
Q4 2021$1,285,000
+59.2%
98,646
+14.7%
0.00%
Q3 2021$807,000
+34.5%
86,033
+46.9%
0.00%
Q2 2021$600,000
-45.8%
58,574
-2.5%
0.00%
Q1 2021$1,106,000
-66.7%
60,088
-66.6%
0.00%
-100.0%
Q3 2020$3,322,000179,9330.00%
Other shareholders
ATHIRA PHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
VR Adviser, LLC 1,691,623$57,938,0008.52%
ACUTA CAPITAL PARTNERS, LLC 393,000$13,460,0003.66%
Logos Global Management LP 947,873$32,465,0002.78%
RTW INVESTMENTS, LP 2,685,779$88,899,0001.49%
Avidity Partners Management LP 1,043,873$35,753,0001.16%
Perceptive Advisors 3,114,805$106,682,0001.14%
Sofinnova Investments, Inc. 509,168$17,439,0001.04%
HighVista Strategies LLC 32,062$1,098,0000.70%
Rock Springs Capital Management LP 860,902$29,486,0000.62%
PFM Health Sciences, LP 470,227$16,105,0000.57%
View complete list of ATHIRA PHARMA INC shareholders